HEADER OXIDOREDUCTASE 20-APR-99 1QBG TITLE CRYSTAL STRUCTURE OF HUMAN DT-DIAPHORASE (NAD(P)H OXIDOREDUCTASE) COMPND MOL_ID: 1; COMPND 2 MOLECULE: NAD(P)H DEHYDROGENASE [QUINONE] 1; COMPND 3 CHAIN: A, B, C, D; COMPND 4 SYNONYM: DT-DIAPHORASE (NAD(P)H OXIDOREDUCTASE (QUINONE), QUINONE COMPND 5 REDUCTASE, DT-DIAPHORASE, DTD, NAD(P)H MENADIONE OXIDOREDUCTASE 1, COMPND 6 DIOXIN-INDUCIBLE; COMPND 7 EC: 1.6.99.2; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS QUINONE, FAD, OXIDOREDUCTASE, DT-DIAPHORASE EXPDTA X-RAY DIFFRACTION AUTHOR J.V.SKELLY,M.R.SANDERSON,D.A.SUTER,U.BAUMANN,D.S.GREGORY,M.BENNETT, AUTHOR 2 S.M.HOBBS,S.NEIDLE REVDAT 5 14-FEB-24 1QBG 1 REMARK REVDAT 4 04-OCT-17 1QBG 1 REMARK REVDAT 3 13-JUL-11 1QBG 1 VERSN REVDAT 2 24-FEB-09 1QBG 1 VERSN REVDAT 1 24-APR-00 1QBG 0 JRNL AUTH J.V.SKELLY,M.R.SANDERSON,D.A.SUTER,U.BAUMANN,M.A.READ, JRNL AUTH 2 D.S.GREGORY,M.BENNETT,S.M.HOBBS,S.NEIDLE JRNL TITL CRYSTAL STRUCTURE OF HUMAN DT-DIAPHORASE: A MODEL FOR JRNL TITL 2 INTERACTION WITH THE CYTOTOXIC PRODRUG JRNL TITL 3 5-(AZIRIDIN-1-YL)-2,4-DINITROBENZAMIDE (CB1954). JRNL REF J.MED.CHEM. V. 42 4325 1999 JRNL REFN ISSN 0022-2623 JRNL PMID 10543876 JRNL DOI 10.1021/JM991060M REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.851 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 4.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 43746 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.232 REMARK 3 FREE R VALUE : 0.280 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.300 REMARK 3 FREE R VALUE TEST SET COUNT : 1867 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 8669 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 212 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: USED X-PLOR PROCEDURE REMARK 4 REMARK 4 1QBG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 20-APR-99. REMARK 100 THE DEPOSITION ID IS D_1000009042. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-OCT-96 REMARK 200 TEMPERATURE (KELVIN) : 298 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS II REMARK 200 INTENSITY-INTEGRATION SOFTWARE : R-AXIS REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 43746 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 4.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.13200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 4.9800 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.40 REMARK 200 COMPLETENESS FOR SHELL (%) : 70.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.60000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.66 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.44 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: SITTING DROP, PEG4000, CYMAL-3 REMARK 280 DETERGENT, SODIUM PHOSPHATE, PH 7.5, VAPOR DIFFUSION, SITTING REMARK 280 DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4, 5, 6 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 5 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 8190 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 21500 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -48.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 6 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 8290 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 21370 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -47.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 VAL B 2 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 209 NZ REMARK 470 LYS B 209 NZ REMARK 470 LYS C 209 NZ REMARK 470 LYS D 209 NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE1 GLN A 243 OE1 GLN B 158 1.82 REMARK 500 OE1 GLN A 243 NE2 GLN B 158 1.92 REMARK 500 OE1 GLN A 243 CD GLN B 158 2.05 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG B 3 NE - CZ - NH2 ANGL. DEV. = 3.2 DEGREES REMARK 500 ARG B 4 NE - CZ - NH2 ANGL. DEV. = 3.3 DEGREES REMARK 500 VAL C 2 CB - CA - C ANGL. DEV. = -24.6 DEGREES REMARK 500 VAL C 2 N - CA - C ANGL. DEV. = 42.7 DEGREES REMARK 500 ARG C 3 N - CA - CB ANGL. DEV. = -23.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 3 -19.54 87.27 REMARK 500 GLU A 123 -25.31 73.88 REMARK 500 ALA A 130 67.68 -157.59 REMARK 500 TYR A 132 -125.69 44.95 REMARK 500 SER A 173 -61.28 -100.55 REMARK 500 ILE A 175 -62.21 -100.89 REMARK 500 PHE A 181 151.27 -48.13 REMARK 500 SER A 191 58.78 28.13 REMARK 500 ASN A 213 27.46 -144.13 REMARK 500 ASN A 231 148.60 165.82 REMARK 500 ASN A 248 32.80 -91.59 REMARK 500 HIS A 257 51.14 -106.58 REMARK 500 LEU A 259 13.27 55.25 REMARK 500 ARG A 272 160.88 81.48 REMARK 500 GLU B 123 -25.67 74.24 REMARK 500 ALA B 130 67.62 -157.96 REMARK 500 TYR B 132 -125.75 43.71 REMARK 500 SER B 173 -62.00 -100.05 REMARK 500 ILE B 175 -62.33 -101.38 REMARK 500 PHE B 181 150.86 -47.48 REMARK 500 SER B 191 58.84 27.82 REMARK 500 ASN B 231 148.99 166.18 REMARK 500 ASN B 248 34.21 -93.72 REMARK 500 HIS B 257 51.18 -106.13 REMARK 500 LEU B 259 13.74 54.99 REMARK 500 ARG B 272 76.66 23.34 REMARK 500 GLU C 123 -25.99 73.84 REMARK 500 ALA C 130 67.85 -157.93 REMARK 500 TYR C 132 -125.65 43.50 REMARK 500 ASP C 133 -15.45 -50.00 REMARK 500 SER C 173 -61.94 -100.03 REMARK 500 ILE C 175 -61.76 -101.79 REMARK 500 PHE C 181 150.49 -48.78 REMARK 500 SER C 191 58.97 27.91 REMARK 500 ASN C 231 148.47 166.05 REMARK 500 ASN C 248 32.73 -92.21 REMARK 500 HIS C 257 51.37 -106.43 REMARK 500 LEU C 259 13.11 55.77 REMARK 500 ARG D 3 -19.08 87.20 REMARK 500 GLU D 123 -25.86 73.93 REMARK 500 ALA D 130 67.67 -157.58 REMARK 500 TYR D 132 -125.90 43.64 REMARK 500 ASP D 133 -15.57 -49.81 REMARK 500 SER D 173 -61.82 -100.60 REMARK 500 ILE D 175 -63.19 -101.27 REMARK 500 PHE D 181 151.02 -48.86 REMARK 500 SER D 191 59.29 27.22 REMARK 500 ASN D 231 148.74 165.77 REMARK 500 ASN D 248 33.41 -92.45 REMARK 500 HIS D 257 51.31 -105.75 REMARK 500 REMARK 500 THIS ENTRY HAS 52 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FAD A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FAD B 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FAD D 701 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FAD C 801 DBREF 1QBG A 2 273 UNP P15559 NQO1_HUMAN 3 274 DBREF 1QBG B 2 273 UNP P15559 NQO1_HUMAN 3 274 DBREF 1QBG C 2 273 UNP P15559 NQO1_HUMAN 3 274 DBREF 1QBG D 2 273 UNP P15559 NQO1_HUMAN 3 274 SEQADV 1QBG VAL A 2 UNP P15559 GLY 3 CONFLICT SEQADV 1QBG VAL B 2 UNP P15559 GLY 3 CONFLICT SEQADV 1QBG VAL C 2 UNP P15559 GLY 3 CONFLICT SEQADV 1QBG VAL D 2 UNP P15559 GLY 3 CONFLICT SEQRES 1 A 272 VAL ARG ARG ALA LEU ILE VAL LEU ALA HIS SER GLU ARG SEQRES 2 A 272 THR SER PHE ASN TYR ALA MET LYS GLU ALA ALA ALA ALA SEQRES 3 A 272 ALA LEU LYS LYS LYS GLY TRP GLU VAL VAL GLU SER ASP SEQRES 4 A 272 LEU TYR ALA MET ASN PHE ASN PRO ILE ILE SER ARG LYS SEQRES 5 A 272 ASP ILE THR GLY LYS LEU LYS ASP PRO ALA ASN PHE GLN SEQRES 6 A 272 TYR PRO ALA GLU SER VAL LEU ALA TYR LYS GLU GLY HIS SEQRES 7 A 272 LEU SER PRO ASP ILE VAL ALA GLU GLN LYS LYS LEU GLU SEQRES 8 A 272 ALA ALA ASP LEU VAL ILE PHE GLN PHE PRO LEU GLN TRP SEQRES 9 A 272 PHE GLY VAL PRO ALA ILE LEU LYS GLY TRP PHE GLU ARG SEQRES 10 A 272 VAL PHE ILE GLY GLU PHE ALA TYR THR TYR ALA ALA MET SEQRES 11 A 272 TYR ASP LYS GLY PRO PHE ARG SER LYS LYS ALA VAL LEU SEQRES 12 A 272 SER ILE THR THR GLY GLY SER GLY SER MET TYR SER LEU SEQRES 13 A 272 GLN GLY ILE HIS GLY ASP MET ASN VAL ILE LEU TRP PRO SEQRES 14 A 272 ILE GLN SER GLY ILE LEU HIS PHE CYS GLY PHE GLN VAL SEQRES 15 A 272 LEU GLU PRO GLN LEU THR TYR SER ILE GLY HIS THR PRO SEQRES 16 A 272 ALA ASP ALA ARG ILE GLN ILE LEU GLU GLY TRP LYS LYS SEQRES 17 A 272 ARG LEU GLU ASN ILE TRP ASP GLU THR PRO LEU TYR PHE SEQRES 18 A 272 ALA PRO SER SER LEU PHE ASP LEU ASN PHE GLN ALA GLY SEQRES 19 A 272 PHE LEU MET LYS LYS GLU VAL GLN ASP GLU GLU LYS ASN SEQRES 20 A 272 LYS LYS PHE GLY LEU SER VAL GLY HIS HIS LEU GLY LYS SEQRES 21 A 272 SER ILE PRO THR ASP ASN GLN ILE LYS ALA ARG LYS SEQRES 1 B 272 VAL ARG ARG ALA LEU ILE VAL LEU ALA HIS SER GLU ARG SEQRES 2 B 272 THR SER PHE ASN TYR ALA MET LYS GLU ALA ALA ALA ALA SEQRES 3 B 272 ALA LEU LYS LYS LYS GLY TRP GLU VAL VAL GLU SER ASP SEQRES 4 B 272 LEU TYR ALA MET ASN PHE ASN PRO ILE ILE SER ARG LYS SEQRES 5 B 272 ASP ILE THR GLY LYS LEU LYS ASP PRO ALA ASN PHE GLN SEQRES 6 B 272 TYR PRO ALA GLU SER VAL LEU ALA TYR LYS GLU GLY HIS SEQRES 7 B 272 LEU SER PRO ASP ILE VAL ALA GLU GLN LYS LYS LEU GLU SEQRES 8 B 272 ALA ALA ASP LEU VAL ILE PHE GLN PHE PRO LEU GLN TRP SEQRES 9 B 272 PHE GLY VAL PRO ALA ILE LEU LYS GLY TRP PHE GLU ARG SEQRES 10 B 272 VAL PHE ILE GLY GLU PHE ALA TYR THR TYR ALA ALA MET SEQRES 11 B 272 TYR ASP LYS GLY PRO PHE ARG SER LYS LYS ALA VAL LEU SEQRES 12 B 272 SER ILE THR THR GLY GLY SER GLY SER MET TYR SER LEU SEQRES 13 B 272 GLN GLY ILE HIS GLY ASP MET ASN VAL ILE LEU TRP PRO SEQRES 14 B 272 ILE GLN SER GLY ILE LEU HIS PHE CYS GLY PHE GLN VAL SEQRES 15 B 272 LEU GLU PRO GLN LEU THR TYR SER ILE GLY HIS THR PRO SEQRES 16 B 272 ALA ASP ALA ARG ILE GLN ILE LEU GLU GLY TRP LYS LYS SEQRES 17 B 272 ARG LEU GLU ASN ILE TRP ASP GLU THR PRO LEU TYR PHE SEQRES 18 B 272 ALA PRO SER SER LEU PHE ASP LEU ASN PHE GLN ALA GLY SEQRES 19 B 272 PHE LEU MET LYS LYS GLU VAL GLN ASP GLU GLU LYS ASN SEQRES 20 B 272 LYS LYS PHE GLY LEU SER VAL GLY HIS HIS LEU GLY LYS SEQRES 21 B 272 SER ILE PRO THR ASP ASN GLN ILE LYS ALA ARG LYS SEQRES 1 C 272 VAL ARG ARG ALA LEU ILE VAL LEU ALA HIS SER GLU ARG SEQRES 2 C 272 THR SER PHE ASN TYR ALA MET LYS GLU ALA ALA ALA ALA SEQRES 3 C 272 ALA LEU LYS LYS LYS GLY TRP GLU VAL VAL GLU SER ASP SEQRES 4 C 272 LEU TYR ALA MET ASN PHE ASN PRO ILE ILE SER ARG LYS SEQRES 5 C 272 ASP ILE THR GLY LYS LEU LYS ASP PRO ALA ASN PHE GLN SEQRES 6 C 272 TYR PRO ALA GLU SER VAL LEU ALA TYR LYS GLU GLY HIS SEQRES 7 C 272 LEU SER PRO ASP ILE VAL ALA GLU GLN LYS LYS LEU GLU SEQRES 8 C 272 ALA ALA ASP LEU VAL ILE PHE GLN PHE PRO LEU GLN TRP SEQRES 9 C 272 PHE GLY VAL PRO ALA ILE LEU LYS GLY TRP PHE GLU ARG SEQRES 10 C 272 VAL PHE ILE GLY GLU PHE ALA TYR THR TYR ALA ALA MET SEQRES 11 C 272 TYR ASP LYS GLY PRO PHE ARG SER LYS LYS ALA VAL LEU SEQRES 12 C 272 SER ILE THR THR GLY GLY SER GLY SER MET TYR SER LEU SEQRES 13 C 272 GLN GLY ILE HIS GLY ASP MET ASN VAL ILE LEU TRP PRO SEQRES 14 C 272 ILE GLN SER GLY ILE LEU HIS PHE CYS GLY PHE GLN VAL SEQRES 15 C 272 LEU GLU PRO GLN LEU THR TYR SER ILE GLY HIS THR PRO SEQRES 16 C 272 ALA ASP ALA ARG ILE GLN ILE LEU GLU GLY TRP LYS LYS SEQRES 17 C 272 ARG LEU GLU ASN ILE TRP ASP GLU THR PRO LEU TYR PHE SEQRES 18 C 272 ALA PRO SER SER LEU PHE ASP LEU ASN PHE GLN ALA GLY SEQRES 19 C 272 PHE LEU MET LYS LYS GLU VAL GLN ASP GLU GLU LYS ASN SEQRES 20 C 272 LYS LYS PHE GLY LEU SER VAL GLY HIS HIS LEU GLY LYS SEQRES 21 C 272 SER ILE PRO THR ASP ASN GLN ILE LYS ALA ARG LYS SEQRES 1 D 272 VAL ARG ARG ALA LEU ILE VAL LEU ALA HIS SER GLU ARG SEQRES 2 D 272 THR SER PHE ASN TYR ALA MET LYS GLU ALA ALA ALA ALA SEQRES 3 D 272 ALA LEU LYS LYS LYS GLY TRP GLU VAL VAL GLU SER ASP SEQRES 4 D 272 LEU TYR ALA MET ASN PHE ASN PRO ILE ILE SER ARG LYS SEQRES 5 D 272 ASP ILE THR GLY LYS LEU LYS ASP PRO ALA ASN PHE GLN SEQRES 6 D 272 TYR PRO ALA GLU SER VAL LEU ALA TYR LYS GLU GLY HIS SEQRES 7 D 272 LEU SER PRO ASP ILE VAL ALA GLU GLN LYS LYS LEU GLU SEQRES 8 D 272 ALA ALA ASP LEU VAL ILE PHE GLN PHE PRO LEU GLN TRP SEQRES 9 D 272 PHE GLY VAL PRO ALA ILE LEU LYS GLY TRP PHE GLU ARG SEQRES 10 D 272 VAL PHE ILE GLY GLU PHE ALA TYR THR TYR ALA ALA MET SEQRES 11 D 272 TYR ASP LYS GLY PRO PHE ARG SER LYS LYS ALA VAL LEU SEQRES 12 D 272 SER ILE THR THR GLY GLY SER GLY SER MET TYR SER LEU SEQRES 13 D 272 GLN GLY ILE HIS GLY ASP MET ASN VAL ILE LEU TRP PRO SEQRES 14 D 272 ILE GLN SER GLY ILE LEU HIS PHE CYS GLY PHE GLN VAL SEQRES 15 D 272 LEU GLU PRO GLN LEU THR TYR SER ILE GLY HIS THR PRO SEQRES 16 D 272 ALA ASP ALA ARG ILE GLN ILE LEU GLU GLY TRP LYS LYS SEQRES 17 D 272 ARG LEU GLU ASN ILE TRP ASP GLU THR PRO LEU TYR PHE SEQRES 18 D 272 ALA PRO SER SER LEU PHE ASP LEU ASN PHE GLN ALA GLY SEQRES 19 D 272 PHE LEU MET LYS LYS GLU VAL GLN ASP GLU GLU LYS ASN SEQRES 20 D 272 LYS LYS PHE GLY LEU SER VAL GLY HIS HIS LEU GLY LYS SEQRES 21 D 272 SER ILE PRO THR ASP ASN GLN ILE LYS ALA ARG LYS HET FAD A 501 53 HET FAD B 601 53 HET FAD C 801 53 HET FAD D 701 53 HETNAM FAD FLAVIN-ADENINE DINUCLEOTIDE FORMUL 5 FAD 4(C27 H33 N9 O15 P2) HELIX 1 1 SER A 16 LYS A 32 1 17 HELIX 2 2 SER A 51 ASP A 54 5 4 HELIX 3 3 GLN A 66 GLY A 78 1 13 HELIX 4 4 SER A 81 ALA A 94 1 14 HELIX 5 5 PRO A 109 PHE A 120 1 12 HELIX 6 6 MET A 131 GLY A 135 5 5 HELIX 7 7 SER A 151 SER A 156 5 6 HELIX 8 8 ASP A 163 SER A 173 1 11 HELIX 9 9 LEU A 176 GLY A 180 5 5 HELIX 10 10 SER A 191 THR A 195 5 5 HELIX 11 11 PRO A 196 LEU A 211 1 16 HELIX 12 12 GLU A 212 GLU A 217 5 6 HELIX 13 13 PRO A 224 LEU A 227 5 4 HELIX 14 14 LYS A 239 LYS A 247 1 9 HELIX 15 15 SER B 16 LYS B 32 1 17 HELIX 16 16 SER B 51 ASP B 54 5 4 HELIX 17 17 GLN B 66 GLY B 78 1 13 HELIX 18 18 SER B 81 ALA B 94 1 14 HELIX 19 19 PRO B 109 PHE B 120 1 12 HELIX 20 20 MET B 131 GLY B 135 5 5 HELIX 21 21 SER B 151 SER B 156 5 6 HELIX 22 22 ASP B 163 SER B 173 1 11 HELIX 23 23 LEU B 176 GLY B 180 5 5 HELIX 24 24 SER B 191 THR B 195 5 5 HELIX 25 25 PRO B 196 LEU B 211 1 16 HELIX 26 26 GLU B 212 GLU B 217 5 6 HELIX 27 27 PRO B 224 LEU B 227 5 4 HELIX 28 28 LYS B 239 LYS B 247 1 9 HELIX 29 29 SER C 16 LYS C 32 1 17 HELIX 30 30 SER C 51 ASP C 54 5 4 HELIX 31 31 GLN C 66 GLY C 78 1 13 HELIX 32 32 SER C 81 ALA C 94 1 14 HELIX 33 33 PRO C 109 PHE C 120 1 12 HELIX 34 34 MET C 131 GLY C 135 5 5 HELIX 35 35 SER C 151 SER C 156 5 6 HELIX 36 36 ASP C 163 SER C 173 1 11 HELIX 37 37 LEU C 176 GLY C 180 5 5 HELIX 38 38 SER C 191 THR C 195 5 5 HELIX 39 39 PRO C 196 LEU C 211 1 16 HELIX 40 40 GLU C 212 GLU C 217 5 6 HELIX 41 41 PRO C 224 LEU C 227 5 4 HELIX 42 42 LYS C 239 LYS C 247 1 9 HELIX 43 43 SER D 16 LYS D 32 1 17 HELIX 44 44 SER D 51 ASP D 54 5 4 HELIX 45 45 GLN D 66 GLY D 78 1 13 HELIX 46 46 SER D 81 ALA D 94 1 14 HELIX 47 47 PRO D 109 PHE D 120 1 12 HELIX 48 48 MET D 131 GLY D 135 5 5 HELIX 49 49 SER D 151 SER D 156 5 6 HELIX 50 50 ASP D 163 SER D 173 1 11 HELIX 51 51 LEU D 176 GLY D 180 5 5 HELIX 52 52 SER D 191 THR D 195 5 5 HELIX 53 53 PRO D 196 LEU D 211 1 16 HELIX 54 54 GLU D 212 GLU D 217 5 6 HELIX 55 55 PRO D 224 LEU D 227 5 4 HELIX 56 56 LYS D 239 LYS D 247 1 9 SHEET 1 A 3 GLU A 35 ASP A 40 0 SHEET 2 A 3 ARG A 4 LEU A 9 1 N ALA A 5 O GLU A 35 SHEET 3 A 3 GLU A 35 ASP A 40 1 O GLU A 35 N ALA A 5 SHEET 1 A1 3 GLU A 35 ASP A 40 0 SHEET 2 A1 3 ARG A 4 LEU A 9 1 N ALA A 5 O GLU A 35 SHEET 3 A1 3 GLU A 35 ASP A 40 1 O GLU A 35 N ALA A 5 SHEET 1 B 3 GLU B 35 ASP B 40 0 SHEET 2 B 3 ARG B 4 LEU B 9 1 N ALA B 5 O GLU B 35 SHEET 3 B 3 GLU B 35 ASP B 40 1 O GLU B 35 N ALA B 5 SHEET 1 B1 3 GLU B 35 ASP B 40 0 SHEET 2 B1 3 ARG B 4 LEU B 9 1 N ALA B 5 O GLU B 35 SHEET 3 B1 3 GLU B 35 ASP B 40 1 O GLU B 35 N ALA B 5 SHEET 1 C 3 GLU C 35 ASP C 40 0 SHEET 2 C 3 ARG C 4 LEU C 9 1 N ALA C 5 O GLU C 35 SHEET 3 C 3 GLU C 35 ASP C 40 1 O GLU C 35 N ALA C 5 SHEET 1 C1 3 GLU C 35 ASP C 40 0 SHEET 2 C1 3 ARG C 4 LEU C 9 1 N ALA C 5 O GLU C 35 SHEET 3 C1 3 GLU C 35 ASP C 40 1 O GLU C 35 N ALA C 5 SHEET 1 D 3 GLU D 35 ASP D 40 0 SHEET 2 D 3 ARG D 4 LEU D 9 1 N ALA D 5 O GLU D 35 SHEET 3 D 3 GLU D 35 ASP D 40 1 O GLU D 35 N ALA D 5 SHEET 1 D1 3 GLU D 35 ASP D 40 0 SHEET 2 D1 3 ARG D 4 LEU D 9 1 N ALA D 5 O GLU D 35 SHEET 3 D1 3 GLU D 35 ASP D 40 1 O GLU D 35 N ALA D 5 SITE 1 AC1 19 HIS A 11 THR A 15 SER A 16 PHE A 17 SITE 2 AC1 19 ASN A 18 ALA A 20 PRO A 102 LEU A 103 SITE 3 AC1 19 GLN A 104 TRP A 105 PHE A 106 THR A 147 SITE 4 AC1 19 THR A 148 GLY A 149 GLY A 150 TYR A 155 SITE 5 AC1 19 ILE A 192 ARG A 200 LEU A 204 SITE 1 AC2 18 HIS B 11 THR B 15 SER B 16 PHE B 17 SITE 2 AC2 18 ASN B 18 ALA B 20 PRO B 102 LEU B 103 SITE 3 AC2 18 GLN B 104 TRP B 105 PHE B 106 THR B 147 SITE 4 AC2 18 THR B 148 GLY B 149 GLY B 150 TYR B 155 SITE 5 AC2 18 ILE B 192 ARG B 200 SITE 1 AC3 21 TYR C 67 GLU C 117 HIS D 11 THR D 15 SITE 2 AC3 21 SER D 16 PHE D 17 ASN D 18 ALA D 20 SITE 3 AC3 21 PRO D 102 LEU D 103 GLN D 104 TRP D 105 SITE 4 AC3 21 PHE D 106 THR D 147 THR D 148 GLY D 149 SITE 5 AC3 21 GLY D 150 TYR D 155 ILE D 192 ARG D 200 SITE 6 AC3 21 LEU D 204 SITE 1 AC4 19 HIS C 11 THR C 15 SER C 16 PHE C 17 SITE 2 AC4 19 ASN C 18 ALA C 20 PRO C 102 LEU C 103 SITE 3 AC4 19 GLN C 104 TRP C 105 PHE C 106 THR C 147 SITE 4 AC4 19 THR C 148 GLY C 149 GLY C 150 TYR C 155 SITE 5 AC4 19 ILE C 192 ARG C 200 LEU C 204 CRYST1 55.880 57.490 98.770 77.10 76.20 86.90 P 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017895 -0.000969 -0.004287 0.00000 SCALE2 0.000000 0.017420 -0.003871 0.00000 SCALE3 0.000000 0.000000 0.010680 0.00000